Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 2.078
Filtrer
1.
Ital J Pediatr ; 49(1): 35, 2023 Mar 21.
Article de Anglais | MEDLINE | ID: mdl-36945009

RÉSUMÉ

BACKGROUND: To date, no studies on presepsin values in cord blood of term infants with risk factors for early-onset sepsis (EOS) are available, whereas only one study reported presepsin values in cord blood of preterm infants at risk. In this study, we investigated the presepsin values in cord blood of term and preterm infants with documented risk factors for EOS. METHODS: In this single-center prospective pilot study, we enrolled neonates presenting with documented risk factors for EOS. P-SEP levels were assessed in a blood sample collected from the clamped umbilical cord after the delivery in 93 neonates, using a point-of-care device. The primary outcome of our study was to evaluate the role of cord blood P-SEP in predicting clinical EOS in term and preterm infants. RESULTS: During the study period, we enrolled 93 neonates with risk factors for EOS with a gestational age ranging between 24.6 and 41.6 weeks (median 38.0). The median P-SEP value in all infants was 491 pg/ml (IQR 377 - 729). Median cord P-SEP values were significantly higher in infants with clinical sepsis (909 pg/ml, IQR 586 - 1307) rather than in infants without (467 pg/ml, IQR 369 - 635) (p = 0.010). We found a statistically significant correlation between cord P-SEP value at birth and the later diagnosis of clinical sepsis (Kendall's τ coefficient 0.222, p = 0.002). We identified the maximum Youden's Index (best cut-off point) at 579 pg/ml, corresponding to a sensitivity of 87.5% and a specificity of 71.8% in predicting clinical sepsis. CONCLUSIONS: Maximum Youden's index was 579 pg/ml for clinical EOS using cord P-SEP values. This could be the starting point to realize multicenter studies, confirming the feasibility of dosing P-SEP in cord blood of infants with risk factors of EOS to discriminate those who could develop clinical sepsis and spare the inappropriate use of antibiotics.


Sujet(s)
Sang foetal , Prématuré , Antigènes CD14 , Sepsis néonatal , Fragments peptidiques , Naissance à terme , Femelle , Humains , Nourrisson , Nouveau-né/sang , Marqueurs biologiques/sang , Sang foetal/composition chimique , Prématuré/sang , Antigènes CD14/sang , Sepsis néonatal/sang , Sepsis néonatal/diagnostic , Fragments peptidiques/sang , Projets pilotes , Études prospectives , Sepsie/sang , Sepsie/diagnostic , Naissance à terme/sang , Facteurs de risque
2.
Horm Res Paediatr ; 94(5-6): 168-175, 2021.
Article de Anglais | MEDLINE | ID: mdl-34348285

RÉSUMÉ

Estradiol (E), testosterone (T), and their ratio are crucial axis in life. Especially during intrauterine growth, they orchestrate the complex development of organs and their interaction, which have lifelong impact on health and an organism's capacity to respond to environmental stressors. The aim of this study was to compare for the first time E, T, and their ratio levels with aromatase (CYP19) gene methylation levels between preterm newborns (PN) and full-term newborns (FN) with respect to their mother's environmental exposure and diet. In this study, 56 FN of 37-42 weeks of gestation age (GA) and 46 PN at GA 27-36 weeks were analysed for E and T levels and CYP19A1 gene pI.3/II promoter region methylation. Results showed there was no difference in E levels between PN and FN, but there were significantly lower levels of T in PN than in FN (2.81 nmol vs. 3.76 nmol, respectively) and consequently a significantly higher E/T ratio in PN than in FN (5278.04 vs. 2891.23, respectively). CYP19A1 methylation was significantly lower in PN than in FN (86.04% vs. 90.04%, respectively). CYP19A1 methylation was significantly reduced in newborns whose mothers reported daily milk consumption. Our study is the first to provide referent values for CYP19A1 methylation levels in FN and PN and shows that PN and FN significantly differ in CYP19A1 methylation levels, T levels, and E/T ratio. Future research should further investigate the mechanisms involved in GA-dependent CYP19A1 methylation levels and mechanisms of sex hormone disturbances which may contribute to preterm birth.


Sujet(s)
Oestradiol/analyse , Développement foetal , Âge gestationnel , Hormones sexuelles stéroïdiennes , Naissance prématurée/sang , Testostérone/analyse , Aromatase/analyse , Aromatase/génétique , Enfant d'âge préscolaire , Oestradiol/sang , Femelle , Sang foetal/composition chimique , Humains , Nourrisson , Nouveau-né/sang , Mâle , Méthylation , Mères , Testostérone/sang
3.
PLoS One ; 16(7): e0254810, 2021.
Article de Anglais | MEDLINE | ID: mdl-34283868

RÉSUMÉ

BACKGROUND: The relationship between severe anemia, red blood cell transfusion and Neonatal necrotizing enterocolitis (NEC) remains controversial. The purpose of this study was to determine the association of severe anemia and RBC transfusion with NEC in neonates. METHODS: The clinical characteristics of NEC were observed in 467 infants with different birth weights from January 2012 to July 2020. A 1:1 ratio case-control study was performed in very low birth weight (VLBW) infants. Severe anemia, RBC transfusion, and confounding factors, including maternal and perinatal complications, feeding, and antibiotics administration were collected in both groups. Univariate and multivariate analyses were used to investigate effects on the risk of NEC. RESULTS: The day of NEC onset and mortality were inversely associated with birth weight. In VLBW infants, adjusting for other factors, severe anemia within 72 h [OR = 2.404, P = 0.016], RBC transfusion within 24 h [OR = 4.905, P = 0.016], within 48 h [OR = 5.587, P = 0.008], and within 72 h [OR = 2.858, P = 0.011] increased the risk of NEC. CONCLUSION: Both severe anemia and RBC transfusion appears to increase the risk of NEC in VLBW infants. The early prevention and treatment of anemia, strict evaluation of the indications for transfusion and enhanced monitoring after transfusion is encouraged in the NICU.


Sujet(s)
Anémie/étiologie , Entérocolite nécrosante/étiologie , Transfusion d'érythrocytes/effets indésirables , Poids de naissance , Études cas-témoins , Femelle , Âge gestationnel , Humains , Nouveau-né/sang , Nouveau-né/métabolisme , Prématuré , Maladies du prématuré/étiologie , Nourrisson très faible poids naissance/physiologie , Mâle , Études rétrospectives , Facteurs de risque
4.
J Perinat Med ; 49(7): 932-935, 2021 Sep 27.
Article de Anglais | MEDLINE | ID: mdl-33857362

RÉSUMÉ

OBJECTIVES: Sphingosine-1-phosphate (S1P) is a signalling lipid involved in embryonic development, physiological homeostasis, and pathogenic processes in multiple organ systems. Disturbance of S1P homeostasis has been associated with various human diseases in which the immune response and vascular integrity are severely compromised. Up-to-date, no study has analyzed S1P levels in neonates. The objective of this study was to determine S1P serum concentrations in neonates and establish S1P reference ranges. METHODS: S1P levels in the umbilical cord blood of 460 term and preterm neonates were compared to a previously described cohort of healthy adult blood donors. S1P levels were further correlated with demographic characteristics, cellular sources of S1P, and inflammatory markers. RESULTS: The median S1P serum level in neonates was 1.70 µmol/L (IQR 1.41-1.97 µmol/L) and significantly higher than normal values reported in adults. S1P levels correlated positively with the number of red blood cells (p<0.001) and negatively with neutrophil precursors (p=0.028). CONCLUSIONS: Elevated S1P levels in neonates compared to adults possibly result from higher S1P content in its cellular sources due to the essential role of S1P during embryogenesis. Generated S1P ranges may be used as reference ranges for future studies in neonates.


Sujet(s)
Sang foetal/métabolisme , Nouveau-né/sang , Lysophospholipides/sang , Sphingosine/analogues et dérivés , Adulte , Marqueurs biologiques/sang , Femelle , Humains , Prématuré/sang , Mâle , Spectrométrie de masse , Études prospectives , Valeurs de référence , Sphingosine/sang
5.
BMC Pregnancy Childbirth ; 21(1): 279, 2021 Apr 08.
Article de Anglais | MEDLINE | ID: mdl-33832462

RÉSUMÉ

BACKGROUND: Vitamin D deficiency is a global public health issue in women and children and is associated with adverse impacts on child growth, such as rickets. However, prior studies have mainly focused on measuring vitamin D levels in singleton pregnant women and their offspring, and very limited studies have revealed the prevalence of vitamin D deficiency in twin pregnant women and their offspring. The aim of this study was to investigate vitamin D levels in twin-pregnant women and their neonates. We also explored the correlation of maternal vitamin D levels with neonatal outcomes and infant growth. METHODS: A prospective subcohort investigation was carried out among 72 dichorionic, diamniotic twin-pregnant mothers and their twin offspring from the Longitudinal Twin Study. Peripheral blood was collected from the mothers in the third trimester, and cord blood was collected from neonates at birth to identify 25[OH]D levels. Data on the characteristics of the mothers and neonates were collected. Infant growth data and food sensitivities were also collected. RESULTS: The average maternal 25[OH]D level was 31.78 ng/mL, with 19.4% being deficient and 20.8% insufficient, while the average neonatal 25[OH]D level was 15.37 ng/mL, with 99.3% being deficiency or insufficient. A positive correlation was found between maternal and neonatal 25[OH]D levels (beta-value: 0.43, 95% CI: 0.37, 0.49). Interestingly, the higher the maternal 25[OH]D level was, the smaller the cotwin birthweight discordance (beta-value: -2.67, 95% CI: - 5.11, - 0.23). In addition, the infants of mothers with vitamin D deficiency were more likely to be allergic to foods at 6 months than those of mothers with vitamin D sufficiency. CONCLUSIONS: Twin neonates were at high risk of vitamin D deficiency, although their mothers' vitamin D deficiency partially improved. Higher maternal vitamin D levels were associated with smaller discordance of cotwin birthweight. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR-OOC-16008203 , 1st April 2016.


Sujet(s)
Sang foetal/composition chimique , Nouveau-né/sang , Grossesse gémellaire/sang , Carence en vitamine D/épidémiologie , Vitamine D/sang , Adulte , Chine/épidémiologie , Femelle , Humains , Nourrisson , Études longitudinales , Mâle , Projets pilotes , Grossesse , Études prospectives , Carence en vitamine D/sang , Carence en vitamine D/diagnostic , Jeune adulte
6.
Am J Epidemiol ; 190(9): 1793-1802, 2021 09 01.
Article de Anglais | MEDLINE | ID: mdl-33778842

RÉSUMÉ

Production of organophosphate esters (OPEs), which represent a major flame-retardant class present in consumer goods, has increased over the past 2 decades. Experimental studies suggest that OPEs may be associated with thyroid hormone disruption, but few human studies have examined this association. We quantified OPE metabolites in the urine of 298 pregnant women from Cincinnati, Ohio, in the Health Outcomes and Measures of the Environment Study (enrolled 2003-2006) at 3 time points (16 and 26 weeks' gestation, and at delivery), and thyroid hormones in 16-week maternal and newborn cord sera. Urinary bis(1,3-dichloro-2-propyl)-phosphate concentrations were generally associated with decreased triiodothyronine and thyroxine levels and increased thyroid-stimulating hormone levels in maternal and newborn thyroid hormones in quartile dose-response analyses and multiple informant models. There was weaker evidence for thyroid hormone alterations in association with diphenyl-phosphate and di-n-butyl-phosphate. Bis-2-chloroethyl-phosphate was not associated with alterations in thyroid hormones in any analyses. We did not observe any evidence of effect modification by infant sex. These results suggest that gestational exposure to some OPEs may influence maternal and neonatal thyroid function, although replication in other cohorts is needed.


Sujet(s)
Nouveau-né/sang , Organophosphates/urine , Effets différés de l'exposition prénatale à des facteurs de risque/induit chimiquement , Hormones thyroïdiennes/sang , Adolescent , Adulte , Exposition environnementale/effets indésirables , Femelle , Sang foetal/composition chimique , Ignifuges/effets indésirables , Humains , Mâle , Adulte d'âge moyen , Organophosphates/effets indésirables , Grossesse , Effets différés de l'exposition prénatale à des facteurs de risque/sang , Thyréostimuline/sang , Thyroxine/sang , Tri-iodothyronine/sang , Jeune adulte
7.
Transfusion ; 61(4): 1080-1092, 2021 04.
Article de Anglais | MEDLINE | ID: mdl-33629748

RÉSUMÉ

BACKGROUND: We hypothesized that variability in practice exists for newborn immunohematology testing due to lack of consensus guidelines. We report the results of a survey assessing that variability at hospitals in the United States and Canada. STUDY DESIGN AND METHODS: An AABB Pediatric Subsection working party developed and validated a survey of newborn immunohematology testing practice. The survey was sent electronically to transfusion service leadership at teaching institutions. RESULTS: The response rate was 67% (61/91); 56 surveys meeting inclusion criteria were analyzed. Approximately 90% (50/56) were from birth hospitals and 16.1% (9/56) were from pediatric hospitals. Newborn immunohematology testing is ordered as a panel by 66.0% (33/50) of birth hospitals. ABO group and DAT is mandated before discharge in 14/56 (25.0%) and 13/56 (23.2%), respectively. About 76.8% (43/56) selectively perform a DAT according to blood blank or clinical parameters. The most common DAT practices include anti-IgG only testing by 73.2% (41/56) and use of umbilical cord specimen type by 67.9% (38/56). A positive DAT is a critical value for 26.8% (15/56) and followed with eluate testing when a maternal antibody screen is positive for 48.2% (27/56). In the setting of a non-ABO maternal red cell antibody, 55.4% (31/56), phenotype neonatal red cells when the DAT is positive. Group O RBC are transfused irrespective of the DAT result for 82.1%, (46/56). CONCLUSION: There is variability in newborn immunohematology testing and transfusion practice and potential overutilization of the DAT. Evidence-based consensus guidelines should be developed to standardize practice and to improve safety.


Sujet(s)
Test de Coombs/statistiques et données numériques , Érythroblastose du nouveau-né/immunologie , Nouveau-né/immunologie , Médecine transfusionnelle/normes , Système ABO de groupes sanguins/immunologie , Anticorps anti-idiotypiques/analyse , Bilirubine/analyse , Canada/épidémiologie , Test de Coombs/normes , Érythroblastose du nouveau-né/diagnostic , Érythroblastose du nouveau-né/épidémiologie , Érythrocytes/immunologie , Sang foetal/immunologie , Sang foetal/métabolisme , Humains , Hyperbilirubinémie/sang , Hyperbilirubinémie/diagnostic , Nourrisson , Nouveau-né/sang , Guides de bonnes pratiques cliniques comme sujet/normes , Prévalence , Études rétrospectives , Enquêtes et questionnaires , États-Unis/épidémiologie
8.
Arch Pathol Lab Med ; 145(1): 66-74, 2021 01 01.
Article de Anglais | MEDLINE | ID: mdl-33367662

RÉSUMÉ

CONTEXT.­: Automated analyzers have advanced the field of clinical hematology, mandating updated complete blood count (CBC) reference intervals (RIs) to be clinically useful. Contemporary newborn CBC RI publications are mostly retrospective, which some authors have cited as one of their cardinal limitations and recommended future prospective studies. OBJECTIVE.­: To prospectively establish accurate hematologic RIs for normal healthy term newborns at 24 hours of life given the limitations of the current medical literature. DESIGN.­: This prospective study was conducted at an academic tertiary care center, and hematology samples were collected from 120 participants deemed to be normal healthy term newborns. Distributions were assessed for normality and tested for outliers. Reference intervals were values between the 2.5th percentile and 97.5th percentile. RESULTS.­: The novel RIs obtained for this study population are as follows: absolute immature granulocyte count, 80/µL to 1700/µL; immature granulocyte percentage, 0.6% to 6.1%; reticulocyte hemoglobin equivalent, 31.7 to 38.4 pg; immature reticulocyte fraction, 35.9% to 52.8%; immature platelet count, 4.73 × 103/µL to 19.72 × 103/µL; and immature platelet fraction, 1.7% to 9.8%. CONCLUSIONS.­: This prospective study has defined hematologic RIs for this newborn population, including new advanced clinical parameters from the Sysmex XN-1000 Automated Hematology Analyzer. These RIs are proposed as the new standard and can serve as a strong foundation for continued research to further explore their value in diagnosing and managing morbidities such as sepsis, anemia, and thrombocytopenia.


Sujet(s)
Hémogramme/normes , Hématologie/normes , Nouveau-né/sang , Femelle , Humains , Mâle , Études prospectives , Valeurs de référence
9.
Am J Perinatol ; 38(12): 1271-1276, 2021 10.
Article de Anglais | MEDLINE | ID: mdl-32498093

RÉSUMÉ

OBJECTIVE: Data on free thyroxine (FT4) concentrations beyond first 2 weeks of preterm infants are limited. This study was aimed to describe the association between perinatal characteristics and FT4 concentrations and the incidence of hypothyroxinemia at 4 weeks. STUDY DESIGN: Retrospective analysis of serum thyroid function tests at 4 weeks in preterm infants <30 weeks of gestation. Association between FT4 at 4 weeks of life and perinatal characteristics were determined by bivariate analysis and multivariable regression. Incidence of hypothyroxinemia was determined using a gestational age adjusted definition based on in utero levels at the equivalent postmenstrual age. RESULTS: The study cohort consisted of 280 infants. FT4 concentrations at 4 weeks of life were significantly associated with gestational age, birth weight, gender, and maternal history of thyroid disease. Hypothyroxinemia was found in 32.8% of the study cohort. CONCLUSION: Perinatal characteristics are associated with FT4 concentrations at 4 weeks of life. Nearly one-third of infants born <30 weeks had hypothyroxinemia at 4 weeks of life when compared with in utero levels at the equivalent postmenstrual age.


Sujet(s)
Nouveau-né/sang , Prématuré/sang , Maladies de la thyroïde/sang , Thyréostimuline/sang , Thyroxine/sang , Femelle , Âge gestationnel , Humains , Très grand prématuré/sang , Mâle , Analyse multifactorielle , Études rétrospectives , Thyroxine/déficit
10.
Am J Perinatol ; 38(S 01): e26-e32, 2021 08.
Article de Anglais | MEDLINE | ID: mdl-32143224

RÉSUMÉ

OBJECTIVE: The lead-in-water impact of the Flint water crisis on the youngest and most neurodevelopmentally vulnerable population was largely unknown. The objective of this study was to investigate and compare cord blood lead levels (CBLLs) in newborns in Flint, Michigan, after the Flint water crisis, to a group of Detroit newborns. STUDY DESIGN: Mothers of 99 Flint newborns were surveyed about potential lead exposures. These neonates were born after the recognition of population-wide lead-in-water contamination. CBLLs were measured and maternal-fetal metrics were reviewed. CBLLs and maternal-fetal metrics were then compared with those of a retrospective cohort of 116 Detroit newborns who previously shared the same water source. Analysis involved descriptive statistics, independent t-test, and χ 2 analysis. RESULTS: CBLLs greater than or equal to 1 µg/dL (0.05 µmol/L) were more prevalent among Flint newborns (14%), as compared with Detroit newborns (2%; p = 0.001). This was a sevenfold disparity between Flint and Detroit newborns. No statistically significant differences were found in birth weight, head circumference, small for gestational age status, gestational age, or preterm status among the two groups. CONCLUSION: The Flint water crisis potentially exposed newborns to lead in utero, implicating maternal-fetal outcomes and future health and development. Primary prevention efforts, including identification and mitigation of lead exposure before conception and during pregnancy, are needed. New environmental exposure detection methods and long-term neurodevelopmental follow-up will complement the findings of this study.


Sujet(s)
Eau de boisson/composition chimique , Sang foetal/composition chimique , Nouveau-né/sang , Plomb/sang , Exposition maternelle/statistiques et données numériques , Poids de naissance , Femelle , Humains , Mâle , Exposition maternelle/effets indésirables , Michigan , Études prospectives , Enquêtes et questionnaires , Polluants chimiques de l'eau/effets indésirables , Polluants chimiques de l'eau/analyse
11.
Am J Perinatol ; 38(3): 258-264, 2021 02.
Article de Anglais | MEDLINE | ID: mdl-31491799

RÉSUMÉ

OBJECTIVE: Breast milk (BM) contains antioxidant molecules which may offer protection against oxidative stress (OS). We aim to investigate oxidant-antioxidant balance in preterm BM during the course of lactation and within a nursing session. STUDY DESIGN: Total antioxidant capacity (TAC) and total oxidant status (TOS) were measured in colostrum, transitional, and mature BM samples of preterm infants born earlier than 34th week of pregnancy and healthy term infants. Oxidative stress index (OSI) was calculated. Foremilk and hindmilk samples were collected separately. RESULTS: In colostrum and transitional milk, TAC (p < 0.001 and p = 0.001, respectively) and TOS (p = 0.005 and p < 0.001, respectively) were lower in preterm BM compared with term BM. OSI was also lower in preterm BM, but it was statistically significant only in transitional milk (p < 0.001). TAC was highest in colostrum and decreased through the course of lactation. However, the decrease in TAC was not statistically significant in preterm BM. Lowest values of TOS and OSI were observed in colostrum. In transitional term BM, hindmilk had a better oxidant-antioxidant profile as indicated by lower TOS and OSI. CONCLUSION: Oxidant-antioxidant balance is preserved in BM in every stage of lactation. Preterm BM has lower OSI which may offer benefits to preterm newborn against OS.


Sujet(s)
Nouveau-né/sang , Prématuré/sang , Lactation/physiologie , Lait humain/composition chimique , Oxydants/métabolisme , Adulte , Antioxydants/analyse , Femelle , Âge gestationnel , Humains , Mâle , Stress oxydatif , Grossesse , Études prospectives , Jeune adulte
12.
Am J Perinatol ; 38(S 01): e92-e101, 2021 08.
Article de Anglais | MEDLINE | ID: mdl-32120418

RÉSUMÉ

OBJECTIVE: This study aimed to establish neonatal serum triglyceride (TG) level reference ranges during lipid infusion and correlate peak TG with neonatal outcomes. STUDY DESIGN: This is a retrospective review of 356 neonates with 696 TG measures obtained in four neonatal intensive care units between 2015 and 2017. TG was evaluated collectively to establish a reference range and a threshold limit. To analyze the effects of a higher TG threshold, neonates were categorized by their peak TG: <180 (TG<180), 180 to 400 (TG180-400), and > 400 mg/dL (TG>400). Univariable and multivariable regression models were constructed to compare peak TG to patient characteristic and clinical outcomes. RESULTS: The frequency of TG > 400 mg/dL was 5% and found only in neonates weighing < 1.5 kg. Neonates in the TG180-400 (n = 91) group were significantly lower in birth weight and gestational age, had lower 5-minute APGAR scores, and had increased ventilatory requirement when compared with neonates in the TG<180 (n = 240) group (all p < 0.001). The TG180-400 group had increased risk of severe intraventricular hemorrhage (p = 0.02) and bronchopulmonary dysplasia (p = 0.03). Elevated TG was associated with mortality (odds ratio [OR]: 14.4, p < 0.001) in univariable analysis, but the relationship weakened (OR: 4.4, p = 0.05) after adjusting for comorbidities in multivariable logistic regression. CONCLUSION: It is unclear if the adverse outcomes seen in neonates with higher peak TG were due to elevated TG alone, or whether illness severity predicted the increased TG. More prospective studies are needed to further delineate the relationships.


Sujet(s)
Émulsion lipidique intraveineuse , Hypertriglycéridémie/mortalité , Nouveau-né/sang , Nutrition parentérale , Triglycéride/sang , Poids de naissance , Dysplasie bronchopulmonaire/sang , Dysplasie bronchopulmonaire/étiologie , Hémorragie cérébrale intraventriculaire/sang , Hémorragie cérébrale intraventriculaire/étiologie , Émulsion lipidique intraveineuse/administration et posologie , Émulsion lipidique intraveineuse/effets indésirables , Femelle , Âge gestationnel , Humains , Hypertriglycéridémie/complications , Nourrisson petit pour son âge gestationnel , Unités de soins intensifs néonatals , Modèles logistiques , Mâle , Odds ratio , Valeurs de référence , Études rétrospectives , Facteurs de risque , Triglycéride/effets indésirables
13.
Am J Perinatol ; 38(14): 1494-1499, 2021 12.
Article de Anglais | MEDLINE | ID: mdl-32683669

RÉSUMÉ

OBJECTIVE: Smoking during pregnancy has harmful effects on the fetus and infant. Although some studies suggest that exposure to fetal-maternal smoking adversely affects both fetal growth and cardiovascular development, the mechanisms and biochemical consequences of smoking in pregnancy and newborns are not yet fully understood. We aimed to investigate whether maternal smoking during pregnancy causes fetal cardiovascular effect by measuring serum asymmetric dimethylarginine (ADMA) level and abdominal aortic intima-media thickness (aIMT). STUDY DESIGN: This prospective study was conducted in newborns of smoking mothers and never-smoker control mothers during their pregnancies. The babies were evaluated echocardiographically on the first day following birth. In two-dimensional mode, abdominal aIMT measurements were performed. ADMA was measured in umbilical cord blood at birth. RESULTS: There were 25 mothers in the study group and 25 mothers in the control group. Serum ADMA levels were 0.459 ± 0.119 µmol/L in the study group and 0.374 ± 0.1127 µmol/L in the control group (p = 0.034). The aIMT value in the study group was 0.84 ± 0.026 mm and the aIMT value in the control group was 0.63 ± 0.011 mm (p = 0.005). CONCLUSION: We found that both the serum ADMA and the aIMT significantly increased in the group with newborns of smoker mothers compared with the group of the newborns of never-smoker mothers. It may also be suggested that exposure to fetal-maternal smoking adversely affects cardiovascular development. KEY POINTS: · It is a known fact that smoking during pregnancy has harmful effects on the development of the fetus and infant.. · We found that both the serum ADMA and aIMT were significantly higher in the group of infants of smoker mothers..


Sujet(s)
Aorte abdominale/anatomie et histologie , Arginine/analogues et dérivés , Fumer des cigarettes/effets indésirables , Nouveau-né/sang , Exposition maternelle/effets indésirables , Tunique intime/anatomie et histologie , Adulte , Aorte abdominale/imagerie diagnostique , Arginine/sang , Études cas-témoins , Échocardiographie , Femelle , Humains , Mâle , Mères , Grossesse , Études prospectives , Fumeurs , Tunique intime/imagerie diagnostique
14.
Obstet Gynecol ; 137(1): 49-55, 2021 01 01.
Article de Anglais | MEDLINE | ID: mdl-33116054

RÉSUMÉ

OBJECTIVE: To investigate the frequency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in parturient women, their partners, and their newborns and the association of such antibodies with obstetric and neonatal outcomes. METHODS: From April 4 to July 3, 2020, in a single university hospital in Denmark, all parturient women and their partners were invited to participate in the study, along with their newborns. Participating women and partners had a pharyngeal swab and a blood sample taken at admission; immediately after delivery, a blood sample was drawn from the umbilical cord. The swabs were analyzed for SARS-CoV-2 RNA by polymerase chain reaction, and the blood samples were analyzed for SARS-CoV-2 antibodies. Full medical history and obstetric and neonatal information were available. RESULTS: A total of 1,313 parturient women (72.5.% of all women admitted for delivery at the hospital in the study period), 1,188 partners, and 1,206 newborns participated in the study. The adjusted serologic prevalence was 2.6% in women and 3.5% in partners. Seventeen newborns had SARS-CoV-2 immunoglobulin G (IgG) antibodies, and none had immunoglobulin M antibodies. No associations between SARS-CoV-2 antibodies and obstetric or neonatal complications were found (eg, preterm birth, preeclampsia, cesarean delivery, Apgar score, low birth weight, umbilical arterial pH, need for continuous positive airway pressure, or neonatal admission), but statistical power to detect such differences was low. Full serologic data from 1,051 families showed an absolute risk of maternal infection of 39% if the partner had antibodies. CONCLUSION: We found no association between SARS-CoV-2 infection and obstetric or neonatal complications. Sixty-seven percent of newborns delivered by mothers with antibodies had SARS-CoV-2 IgG antibodies. A limitation of our study is that we lacked statistical power to detect small but potentially meaningful differences between those with and without evidence of infection.


Sujet(s)
Anticorps antiviraux/sang , Dépistage de la COVID-19/statistiques et données numériques , COVID-19/épidémiologie , Nouveau-né/sang , Partenaire sexuel , Adulte , COVID-19/sang , Danemark/épidémiologie , Femelle , Hospitalisation , Hôpitaux universitaires , Humains , Immunoglobuline G/sang , Immunoglobuline M/sang , Transmission verticale de maladie infectieuse/statistiques et données numériques , Mâle , Complications du travail obstétrical/épidémiologie , Grossesse , Complications infectieuses de la grossesse/épidémiologie , Issue de la grossesse/épidémiologie , Naissance prématurée/épidémiologie , Analyse de régression , Facteurs de risque , SARS-CoV-2/immunologie
15.
N Engl J Med ; 383(27): 2639-2651, 2020 12 31.
Article de Anglais | MEDLINE | ID: mdl-33382931

RÉSUMÉ

BACKGROUND: Limited data suggest that higher hemoglobin thresholds for red-cell transfusions may reduce the risk of cognitive delay among extremely-low-birth-weight infants with anemia. METHODS: We performed an open, multicenter trial in which infants with a birth weight of 1000 g or less and a gestational age between 22 weeks 0 days and 28 weeks 6 days were randomly assigned within 48 hours after delivery to receive red-cell transfusions at higher or lower hemoglobin thresholds until 36 weeks of postmenstrual age or discharge, whichever occurred first. The primary outcome was a composite of death or neurodevelopmental impairment (cognitive delay, cerebral palsy, or hearing or vision loss) at 22 to 26 months of age, corrected for prematurity. RESULTS: A total of 1824 infants (mean birth weight, 756 g; mean gestational age, 25.9 weeks) underwent randomization. There was a between-group difference of 1.9 g per deciliter (19 g per liter) in the pretransfusion mean hemoglobin levels throughout the treatment period. Primary outcome data were available for 1692 infants (92.8%). Of 845 infants in the higher-threshold group, 423 (50.1%) died or survived with neurodevelopmental impairment, as compared with 422 of 847 infants (49.8%) in the lower-threshold group (relative risk adjusted for birth-weight stratum and center, 1.00; 95% confidence interval [CI], 0.92 to 1.10; P = 0.93). At 2 years, the higher- and lower-threshold groups had similar incidences of death (16.2% and 15.0%, respectively) and neurodevelopmental impairment (39.6% and 40.3%, respectively). At discharge from the hospital, the incidences of survival without severe complications were 28.5% and 30.9%, respectively. Serious adverse events occurred in 22.7% and 21.7%, respectively. CONCLUSIONS: In extremely-low-birth-weight infants, a higher hemoglobin threshold for red-cell transfusion did not improve survival without neurodevelopmental impairment at 22 to 26 months of age, corrected for prematurity. (Funded by the National Heart, Lung, and Blood Institute and others; TOP ClinicalTrials.gov number, NCT01702805.).


Sujet(s)
Anémie/thérapie , Transfusion d'érythrocytes , Hémoglobines/analyse , Nourrisson de poids extrêmement faible à la naissance/sang , Très grand prématuré/sang , Maladies du prématuré/thérapie , Troubles du développement neurologique/prévention et contrôle , Algorithmes , Anémie/sang , Anémie/mortalité , Paralysie cérébrale/prévention et contrôle , Troubles de la cognition/prévention et contrôle , Transfusion d'érythrocytes/effets indésirables , Perte d'audition/prévention et contrôle , Humains , Nouveau-né/sang , Prématuré/sang , Maladies du prématuré/sang , Maladies du prématuré/mortalité , Taux de survie , Troubles de la vision/prévention et contrôle
16.
PLoS One ; 15(11): e0242539, 2020.
Article de Anglais | MEDLINE | ID: mdl-33211743

RÉSUMÉ

Platelets parameters including platelet count (PLT), plateletcrit (PCT), mean platelet volume (MPV) and platelet distribution width (PDW) are associated with various physiological and pathological functions in various disease. However, few studies have addressed whether perinatal factors may be associated with platelet parameters at birth in a large cohort of late preterm and term neonates. The aim of this study to investigate perinatal factors affecting platelet parameters in late preterm and term neonates. We retrospectively investigated platelet parameters including PLT, PCT, MPV, and PDW on the first day of life in 142 late preterm and 258 term neonates admitted to our NICU from 2006 through 2020. PLT, MPV, PCT, PDW on Day 0 did not significantly differ between the two groups. In term neonates, multivariate analysis revealed that PCT correlated with being small for gestational age (SGA) (ß = -0.168, P = 0.006), pregnancy induced hypertension (PIH) (ß = -0.135, P = 0.026) and male sex (ß = -0.185, P = 0.002). PLT was associated with SGA (ß = -0.186, P = 0.002), PIH (ß = -0.137, P = 0.024) and male sex (ß = -0.166, P = 0.006). In late preterm neonates, multivariate analysis revealed that PLT were associated with PIH, whereas no factors associated with PDW and MPV were found. In all patients studied, chorioamnionitis (CAM) was significantly associated with MPV (CAM = 10.3 fL vs. no CAM = 9.7 fL, P<0.001). Multivariate analysis showed that SGA, male sex and PIH were associated with PCT and PLT. This study demonstrates that different maternal and neonatal complications affect platelet parameters in late preterm and term neonates.


Sujet(s)
Plaquettes , Nouveau-né/sang , Prématuré/sang , Complications de la grossesse , Lésions prénatales/sang , Score d'Apgar , Poids de naissance , Femelle , Rupture prématurée des membranes foetales , Âge gestationnel , Humains , Hypertension artérielle gravidique , Nourrisson à faible poids de naissance/sang , Nourrisson petit pour son âge gestationnel/sang , Mâle , Volume plaquettaire moyen , Numération des plaquettes , Grossesse , Syndrome de détresse respiratoire du nouveau-né/sang , Études rétrospectives , Facteurs sexuels
17.
J Acquir Immune Defic Syndr ; 85(5): 626-634, 2020 12 15.
Article de Anglais | MEDLINE | ID: mdl-32925360

RÉSUMÉ

BACKGROUND: HIV treatment of neonates requires identifying appropriate antiretroviral dosing regimens. Our aims were to characterize raltegravir elimination kinetics in low birth weight (LBW) neonates after maternal dosing and to develop a pharmacokinetic model to predict raltegravir plasma concentrations for term and preterm neonates. METHODS: Mothers living with HIV who received raltegravir during pregnancy and their LBW neonates participated in IMPAACT P1097 study. Up to 6 serial plasma samples were collected from each infant over the first 2 postnatal weeks to characterize raltegravir elimination. Safety laboratory evaluations were obtained, and infants were monitored for 6 weeks for signs of raltegravir toxicity. An integrated maternal-neonatal pharmacokinetic model was developed to predict neonatal raltegravir plasma concentrations. RESULTS: Sixteen mothers and their 18 LBW neonates were enrolled. The median (range) raltegravir elimination half-life was 24.4 (10.1-83) hours (N = 17 neonates). No adverse events related to raltegravir in utero exposure were observed. Pharmacokinetic modeling revealed that raltegravir clearance in full-term LBW neonates was well described by allometric scaling but clearance in preterm LBW neonates was better described using slower clearance maturation kinetics. Simulations suggest receipt of the current dosing recommendations in a 34-week gestation neonate would result in plasma concentrations up to 2.5-fold higher than those observed in full-term LBW infants. CONCLUSIONS: Modeling suggests that prematurity reduces raltegravir clearance and a modified raltegravir dosing regimen will be necessary to avoid elevated plasma raltegravir concentrations.


Sujet(s)
Agents antiVIH/pharmacocinétique , Nourrisson à faible poids de naissance/métabolisme , Nouveau-né , Prématuré/métabolisme , Raltégravir de potassium/pharmacocinétique , Agents antiVIH/sang , Femelle , Glucuronosyltransferase/génétique , Période , Humains , Nourrisson à faible poids de naissance/sang , Nouveau-né/sang , Nouveau-né/métabolisme , Prématuré/sang , Mâle , Polymorphisme de nucléotide simple/génétique , Raltégravir de potassium/sang
18.
Clin Epigenetics ; 12(1): 134, 2020 09 07.
Article de Anglais | MEDLINE | ID: mdl-32894192

RÉSUMÉ

BACKGROUND: Intrauterine exposure to a disturbed maternal glucose metabolism is associated with adverse offspring outcomes. DNA methylation is a potential mechanism underlying these associations. We examined whether maternal early-pregnancy glucose and insulin concentrations are associated with newborn DNA methylation. In a population-based prospective cohort study among 935 pregnant women, maternal plasma concentrations of non-fasting glucose and insulin were measured at a median of 13.1 weeks of gestation (95% range 9.4-17.4). DNA methylation was measured using the Infinium HumanMethylation450 BeadChip (Ilumina). We analyzed associations of maternal early-pregnancy glucose and insulin concentrations with single-CpG DNA methylation using robust linear regression models. Differentially methylated regions were analyzed using the dmrff package in R. We stratified the analyses on normal weight versus overweight or obese women. We also performed a look-up of CpGs and differently methylated regions from previous studies to be associated with maternal gestational diabetes, hyperglycemia or hyperinsulinemia, or with type 2 diabetes in adults. RESULTS: Maternal early-pregnancy glucose and insulin concentrations were not associated with DNA methylation at single CpGs nor with differentially methylated regions in the total group. In analyses stratified on maternal BMI, maternal early-pregnancy glucose concentrations were associated with DNA methylation at one CpG (cg03617420, XKR6) among normal weight women and at another (cg12081946, IL17D) among overweight or obese women. No stratum-specific associations were found for maternal early-pregnancy insulin concentrations. The two CpGs were not associated with birth weight or childhood glycemic measures (p values > 0.1). Maternal early-pregnancy insulin concentrations were associated with one CpG known to be related to adult type 2 diabetes. Enrichment among nominally significant findings in our maternal early-pregnancy glucose concentrations was found for CpGs identified in a previous study on adult type 2 diabetes. CONCLUSIONS: Maternal early-pregnancy glucose concentrations, but not insulin concentrations, were associated with DNA methylation at one CpG each in the subgroups of normal weight and of overweight or obese women. No associations were present in the full group. The role of these CpGs in mechanisms underlying offspring health outcomes needs further study. Future studies should replicate our results in larger samples with early-pregnancy information on maternal fasting glucose metabolism.


Sujet(s)
Glycémie/analyse , Méthylation de l'ADN/génétique , Nouveau-né/sang , Insuline/analyse , Grossesse/sang , Adulte , Études de cohortes , Ilots CpG/génétique , Diabète de type 2/génétique , Diabète gestationnel/épidémiologie , Diabète gestationnel/génétique , Épigénomique/méthodes , Femelle , Sang foetal/métabolisme , Âge gestationnel , Humains , Interleukine-17/métabolisme , Obésité/génétique , Surpoids/génétique , Études prospectives
19.
Int J Mol Sci ; 21(16)2020 Aug 17.
Article de Anglais | MEDLINE | ID: mdl-32824472

RÉSUMÉ

Therapeutic drug monitoring (TDM) should be adopted in all neonatal intensive care units (NICUs), where the most preterm and fragile babies are hospitalized and treated with many drugs, considering that organs and metabolic pathways undergo deep and progressive maturation processes after birth. Different developmental changes are involved in interindividual variability in response to drugs. A crucial point of TDM is the choice of the bioanalytical method and of the sample to use. TDM in neonates is primarily used for antibiotics, antifungals, and antiepileptic drugs in clinical practice. TDM appears to be particularly promising in specific populations: neonates who undergo therapeutic hypothermia or extracorporeal life support, preterm infants, infants who need a tailored dose of anticancer drugs. This review provides an overview of the latest advances in this field, showing options for a personalized therapy in newborns and infants.


Sujet(s)
Surveillance des médicaments/méthodes , Nouveau-né/sang , Médecine de précision/méthodes , Anti-infectieux/administration et posologie , Anti-infectieux/pharmacocinétique , Anticonvulsivants/administration et posologie , Anticonvulsivants/pharmacocinétique , Voies d'élimination des médicaments , Humains , Nouveau-né/physiologie , Nouveau-né/urine , Taux de clairance métabolique
20.
JNMA J Nepal Med Assoc ; 58(226): 377-382, 2020 Jun 30.
Article de Anglais | MEDLINE | ID: mdl-32788752

RÉSUMÉ

INTRODUCTION: Neonatal sepsis is the most important cause of morbidity and mortality among low birth weight and preterm babies in developing countries. The main objective of this study is to find the level of micro-Erythrocyte sedimentation rate in neonatal sepsis. METHODS: This is a descriptive cross-sectional study conducted at the neonatal unit over six months period (November 2019 to April 2020). All preterm, term and post-term babies with neonatal sepsisdelivered at Kathmandu Medical College Teaching Hospital were enrolled. Ethical clearance was received from the Institutional Review Committee of Kathmandu Medical College (Ref: 181020191). Convenient sampling method was applied and statistical analysis was done with Statistical package for social sciences 19 version. RESULTS: Out of 75 babies, confirm sepsis is 13 (17.3%), probable sepsis is 40 (53.4%) and suspected sepsis is 22 (29.2%). Micro-Erythrocyte sedimentation level is elevated (≥15mm in 1st hr) in 25 (33.3%) babies with a mean micro-Erythrocyte sedimentation level 9.32±5.4 (2-18) mm in 1st hr. The elevated micro- Erythrocyte sedimentation level was seen in relation to sepsis types and C-reactive protein. CONCLUSIONS: The bedside micro-Erythrocyte sedimentation level aids in the diagnosis of neonatal sepsis.


Sujet(s)
Sédimentation du sang , Sepsis néonatal , Études transversales , Femelle , Humains , Nouveau-né/sang , Nourrisson postmature/sang , Mâle , Sepsis néonatal/sang , Sepsis néonatal/diagnostic , Sepsis néonatal/étiologie , Naissance prématurée/sang , Naissance à terme/sang , Centres de soins tertiaires
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...